Recombinant human platelet-derived growth factor-BB combined with grafting materials for the treatment of periodontal intrabony defects: A meta-analysis

Background/Aim. Periodontitis is a common dental disease affecting around 50% of adult patients globally. It can cause continuous deterioration of periodontal tissue inflammation, leading to irreversible periodontal bone resorption and even tooth loosening. Currently, suitable techniques for managing periodontal intrabony deformities include both allogeneic and autologous bone transplantation, but these methods have certain limitations. The aim of this study was to examine the effect of recombinant human platelet-derived growth factor-BB (rhPDGF-BB) in combination with grafting materials for the treatment of periodontal intraosseous defects using a meta-analysis. Methods. In March 2024, electronic databases (Cochrane Library, PubMed, Embase, Web of Science) were searched to gather data from studies on growth factors and grafting materials for the treatment of intrabony periodontal deficiencies. Results. A total of 11 articles were fully re-viewed, of which nine were included in the meta-analysis. The 9 studies included 313 people, divided into two groups: experimental (n = 156) and control (n = 157). The results of the meta-analysis indicate significantly higher clinical attachment level (CAL) of the experimental group [p < 0.01, standardized mean difference (SMD): 0.80; 95% confidence interval (CI): 0.49, 1.10] compared to the control group. Changes in probing depth (PD) of the experimental group were greater (p < 0.01, SMD: 0.75; 95% CI: 0.39, 1.11) than in the control group. In addition, bone fill (BF) (p < 0.01, SMD: 22.33; 95% CI: 15.71, 28.95) and linear bone growth (LBG) (p < 0.01, SMD: 0.87; 95% CI: 0.43, 1.30) of the experimental group were greater. The gingival recession (GR) of the experimental group was lower (p < 0.05, SMD: -0.27; 95% CI: -0.51, -0.03) than in the control group. Conclusion. The results indicate that the rhPDGF-BB combined with the grafting material can improve CAL, PD, BF, LBG, and GR in periodontal intra-bony defects.

Authors

Institutions

Publication Details

Journal
Vojnosanitetski pregled
Published
2025-01-01
DOI
https://doi.org/10.2298/vsp241029019h
Primary Topic
Periodontal Regeneration and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Recombinant human platelet-derived growth factor-BB combined with grafting materials for the treatment of periodontal intrabony defects: A meta-analysis

Hao Wang, Xiaodong Sui, Leilei Li, Kun Huang et al.
Vojnosanitetski pregled
Periodontal Regeneration and Treatments
article

Recombinant human platelet-derived growth factor-BB combined with grafting materials for the treatment of periodontal intrabony defects: A meta-analysis

Hao Wang, Xiaodong Sui, Leilei Li, Kun Huang, Yuanyuan Qi
article en

Abstract

Background/Aim. Periodontitis is a common dental disease affecting around 50% of adult patients globally. It can cause continuous deterioration of periodontal tissue inflammation, leading to irreversible periodontal bone resorption and even tooth loosening. Currently, suitable techniques for managing periodontal intrabony deformities include both allogeneic and autologous bone transplantation, but these methods have certain limitations. The aim of this study was to examine the effect of recombinant human platelet-derived growth factor-BB (rhPDGF-BB) in combination with grafting materials for the treatment of periodontal intraosseous defects using a meta-analysis. Methods. In March 2024, electronic databases (Cochrane Library, PubMed, Embase, Web of Science) were searched to gather data from studies on growth factors and grafting materials for the treatment of intrabony periodontal deficiencies. Results. A total of 11 articles were fully re-viewed, of which nine were included in the meta-analysis. The 9 studies included 313 people, divided into two groups: experimental (n = 156) and control (n = 157). The results of the meta-analysis indicate significantly higher clinical attachment level (CAL) of the experimental group [p < 0.01, standardized mean difference (SMD): 0.80; 95% confidence interval (CI): 0.49, 1.10] compared to the control group. Changes in probing depth (PD) of the experimental group were greater (p < 0.01, SMD: 0.75; 95% CI: 0.39, 1.11) than in the control group. In addition, bone fill (BF) (p < 0.01, SMD: 22.33; 95% CI: 15.71, 28.95) and linear bone growth (LBG) (p < 0.01, SMD: 0.87; 95% CI: 0.43, 1.30) of the experimental group were greater. The gingival recession (GR) of the experimental group was lower (p < 0.05, SMD: -0.27; 95% CI: -0.51, -0.03) than in the control group. Conclusion. The results indicate that the rhPDGF-BB combined with the grafting material can improve CAL, PD, BF, LBG, and GR in periodontal intra-bony defects.

Vojnosanitetski pregledVol. 82(4)
Liaocheng University (CN), Wenzhou Medical University (CN), Dongyang People's Hospital (CN), Liaocheng People's Hospital (CN)
Openalex Percentile: Top 92%
Periodontal Regeneration and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.